At the first stage, tumor-specific fluorescence imaging turn-on and enrichment is an output with the dual actions of tumor microenvironment (characterized by hypoxia, low pH, and high glutathione (GSH) levels) and folate receptor as an input, where fluorescence imaging is enabled by activities of NTR highly expressed in hypoxic regions. The gene discussed is NTSR1; the disease is neoplasm.